|
|
JNJ38877605
Description of:JNJ38877605
JNJ-38877605 is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antineoplas...
More>>
|
|
|
|
Tivantinib(ARQ197)
Description of:Tivantinib(ARQ197)
Exposure to ARQ197(Tivantinib) resulted in the inhibition of proliferation of c-Met–expressing cancer c...
More>>
|
|
|
|
Crizotinib
Description of:Crizotinib
PF-2341066(Crizotinib) showed similar potency against c-Met phosphorylation in mIMCD3 mouse (IC50, 5 nmol/L) or MDCK ...
More>>
|
|
|
|
Masitinib
Description of:Masitinib
Masitinib inhibits wild-type human and murine KIT in vitro with an IC50 of approximately 200 nM, and administered PO m...
More>>
|
|
|
|
CHIR-258(Dovitinib)
Description of:CHIR-258(Dovitinib)
CHIR-258 was highly potent against FLT3 (1 nmol/L) with nanomolar activity against c-KIT (2 nmol/L), VEGFR1/...
More>>
|
|
|
|
Imatinib Mesylate
Description of:Imatinib Mesylate
Imatinib inhibits EOL-1 cell viability (IC50 = 0.5 nM), phosphorylation of a fusion protein (IC50 = 30 nM), an...
More>>
|
|
|
|
NVP-BHG712
Description of:NVP-BHG712
NVP-BHG712 inhibits VEGF driven angiogenesis. In a panel of more than 40 in vitro kinase assays, NVP-BHG712 showed ex...
More>>
|
|
|
|
NVP-TAE684
Description of:NVP-TAE684
NVP-TAE684 is a highly potent and selective smallmolecule ALK inhibitor, which blocked the growth of ALCL-derived and...
More>>
|
|
|
|
SB525334
Description of:SB525334
SB525334 is a selective inhibitor of transforming growth factor-β receptor I (ALK5, TGF-βRI) (IC50=14.3 nM).&...
More>>
|
|
|
|
CH5424802
Description of:CH5424802
CH5424802 is a potent, selective, and orally available ALK inhibitor. which with a unique chemical scaffold, showing p...
More>>
|
|
Neuronal Signaling
BtK
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian